Education
About Us
Working with TipRanks
Follow Us
PureTech Health (GB:PRTC)
:PRTC
PRTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range100.40p - 178.00p
Previous CloseN/A
Volume88.39K
Average Volume (3M)325.13K
Market Cap
£325.78M
Enterprise Value111.25M
Total Cash (Recent Filing)£367.31M
Total Debt (Recent Filing)£22.36M
Price to Earnings (P/E)8.2
Beta2.16
Next Earnings
Aug 27, 2025EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.27
Shares Outstanding241,316,330
10 Day Avg. Volume455,786
30 Day Avg. Volume325,125
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£141.00Price Target Upside2.92% Upside
Rating ConsensusHold
Number of Analyst Covering0
PureTech Health News
PRTC FAQ
What was PureTech Health’s price range in the past 12 months?
PureTech Health lowest share price was 100.40p and its highest was 178.00p in the past 12 months.
What is PureTech Health’s market cap?
PureTech Health’s market cap is £325.78M.
When is PureTech Health’s upcoming earnings report date?
PureTech Health’s upcoming earnings report date is Aug 27, 2025 which is in 19 days.
How were PureTech Health’s earnings last quarter?
PureTech Health released its earnings results on Apr 30, 2025. The company reported 0.27p earnings per share for the quarter, beating the consensus estimate of -0.212p by 0.481p.
Is PureTech Health overvalued?
According to Wall Street analysts PureTech Health’s price is currently Undervalued.
Does PureTech Health pay dividends?
PureTech Health does not currently pay dividends.
What is PureTech Health’s EPS estimate?
PureTech Health’s EPS estimate is -0.15.
How many shares outstanding does PureTech Health have?
PureTech Health has 241,316,330 shares outstanding.
What happened to PureTech Health’s price movement after its last earnings report?
PureTech Health reported an EPS of 0.27p in its last earnings report, beating expectations of -0.212p. Following the earnings report the stock price went down -2.226%.
Which hedge fund is a major shareholder of PureTech Health?
Currently, no hedge funds are holding shares in GB:PRTC
PureTech Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£141.00 (2.92% Upside)
£141.00 (2.92% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.68%
12-Months-Change
Fundamentals
Return on Equity
11.74%
Trailing 12-Months
Asset Growth
-11.61%
Trailing 12-Months
Company Description
PureTech Health
PureTech Health (PRTC) is a biopharmaceutical company based in the United Kingdom, focused on the development and commercialization of novel medicines to address significant unmet medical needs. The company operates primarily in the healthcare and biotechnology sectors, with a strong emphasis on leveraging its unique expertise in lymphatic and immune systems to advance its therapeutic pipeline. PureTech's core products and services revolve around pioneering research and development initiatives, aimed at creating innovative solutions in areas such as immuno-oncology, lymphatics, and inflammation.
Technical Analysis
Oxford BioMedica
―
Scancell Holdings
―
Bioventix
―
4basebio UK Societas
―
Oxford Nanopore Technologies PLC
―
Ownership Overview
3.58% Insiders
11.67%
Mutual Funds
0.11% Other Institutional Investors
82.75% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---